Jazz Pharmaceuticals (JAZZ) Divestments (2015)
Jazz Pharmaceuticals (JAZZ) posted quarterly Divestments of $1.0 million for Q2 2015, down 96.97% quarter-over-quarter from $33.0 million in Q1 2015.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Divestments (2015) Analysis & Trends
Jazz Pharmaceuticals' Divestments history runs 1 years deep, the most recent figure standing at $1.0 million for Q2 2015.
- In Q2 2015, Divestments changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2016 stood at $1.0 million (down 96.97% YoY), while the FY2022 annual figure was $53.0 million, changed N/A from the prior year.
- Divestments for Q2 2015 stood at $1.0 million, down from $33.0 million in the prior quarter.
- The five-year high for Divestments was $33.0 million in Q1 2015, with the low at $1.0 million in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn | - |